在不成比例的危险下,适应性权重选择时间到事件数据
Moritz Fabian Danzer1, Ina Dormuth2
1Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
Statistics in medicine
|March 17, 2025
概括
这项研究引入了对时间到事件终点的灵活临床试验设计,在比例危险假设不确定时提高了稳定性. 适应性的多阶段方法增强了功率和灵活性,节省了可能没有结论的试验.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 生存分析的分析.
背景情况:
- 对于时间到事件终点的标准临床试验通常假设相对的危险,使用单阶段的日志等级测试.
- 这种严格的方法在违反比例危险假设或未知效应大小时存在问题.
- 现有的方法缺乏灵活性,可能导致不确定的试验结果.
研究的目的:
- 引入一个更灵活,更强大的临床试验规划程序,以时间到事件的终点.
- 解决假设比例危险的局限性和缺乏对效应大小的先前知识的局限性.
- 通过提供更具适应性的设计,提高临床试验的成功率.
主要方法:
- 采用适应式多阶段设计,而不是传统的单阶段方法.
- 在初始阶段使用组合类型测试,在不确定的偏差模式下测试稳定性.
- 结合了Royston-Parmar支线模型,用于生存曲线外推,以告知后续阶段.
主要成果:
- 通过一个现实世界的例子表明,拟议的方法可以挽救试验,否则将是不确定的.
- 模拟研究证实了足够的统计功率性能.
- 与标准程序相比,该方法保持了更大的灵活性.
结论:
- 拟议的适应性多阶段程序为具有时间到事件终点的临床试验提供了更灵活和更强大的替代方案.
- 这种方法特别有用,当事先的知识是有限的或比例危险假设是可疑的.
- 该方法提高了试验成功概率和统计能力.
相关概念视频
Parametric Survival Analysis: Weibull and Exponential Methods
319
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
319
Comparing the Survival Analysis of Two or More Groups
113
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
113
Assumptions of Survival Analysis
81
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
81
Introduction To Survival Analysis
150
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
150
Kaplan-Meier Approach
74
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
74
Censoring Survival Data
55
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
55


